Psychemedics Cash on Hand 2012-2024 | PMD
Psychemedics cash on hand from 2012 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
|
Psychemedics Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $1 |
| 2023 | $2 |
| 2022 | $5 |
| 2021 | $2 |
| 2020 | $3 |
| 2019 | $7 |
| 2018 | $8 |
| 2017 | $8 |
| 2016 | $4 |
| 2015 | $3 |
| 2014 | $4 |
| 2013 | $4 |
| 2012 | $3 |
| 2011 | $6 |
|
Psychemedics Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-12-31 | $1 |
| 2024-09-30 | $1 |
| 2024-06-30 | $1 |
| 2024-03-31 | $1 |
| 2023-12-31 | $2 |
| 2023-09-30 | $1 |
| 2023-06-30 | $2 |
| 2023-03-31 | $4 |
| 2022-12-31 | $5 |
| 2022-09-30 | $3 |
| 2022-06-30 | $2 |
| 2022-03-31 | $2 |
| 2021-12-31 | $2 |
| 2021-09-30 | $2 |
| 2021-06-30 | $3 |
| 2021-03-31 | $2 |
| 2020-12-31 | $3 |
| 2020-09-30 | $2 |
| 2020-06-30 | $4 |
| 2020-03-31 | $5 |
| 2019-12-31 | $7 |
| 2019-09-30 | $6 |
| 2019-06-30 | $7 |
| 2019-03-31 | $7 |
| 2018-12-31 | $8 |
| 2018-09-30 | $6 |
| 2018-06-30 | $8 |
| 2018-03-31 | $8 |
| 2017-12-31 | $8 |
| 2017-09-30 | $6 |
| 2017-06-30 | $3 |
| 2017-03-31 | $7 |
| 2016-12-31 | $4 |
| 2016-09-30 | $4 |
| 2016-06-30 | $2 |
| 2016-03-31 | $2 |
| 2015-12-31 | $3 |
| 2015-09-30 | $2 |
| 2015-06-30 | $2 |
| 2015-03-31 | $3 |
| 2014-12-31 | $4 |
| 2014-09-30 | $3 |
| 2014-06-30 | $2 |
| 2014-03-31 | $2 |
| 2013-12-31 | $4 |
| 2013-09-30 | $3 |
| 2013-06-30 | $3 |
| 2013-03-31 | $3 |
| 2012-12-31 | $3 |
| 2012-09-30 | $4 |
| 2012-06-30 | $5 |
| 2012-03-31 | $5 |
| 2011-12-31 | $6 |
| 2011-09-30 | $4 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.000B | $0.020B |
| Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Astrana Health (ASTH) | United States | $2.138B | 22.69 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |